Matching articles for "Issue 1292"

Antiplatelet Therapy for Patients with Stents

   
The Medical Letter on Drugs and Therapeutics • August 11, 2008;  (Issue 1292)
The antiplatelet agents aspirin and clopidogrel (Plavix, and others) are used in most patients undergoing percutaneous coronary intervention (PCI) to prevent stent thrombosis and to reduce the occurrence of...
The antiplatelet agents aspirin and clopidogrel (Plavix, and others) are used in most patients undergoing percutaneous coronary intervention (PCI) to prevent stent thrombosis and to reduce the occurrence of peri-, post-procedural and late cardiovascular events. Despite a large number of randomized trials of these agents in such patients, the optimal dosage and duration of treatment with these drugs, and whether other drugs should be added, is unclear.
Med Lett Drugs Ther. 2008 Aug 11;50(1292):61-3 | Show Full IntroductionHide Full Introduction

Correction: The EarCheck Middle Ear Monitor

   
The Medical Letter on Drugs and Therapeutics • August 11, 2008;  (Issue 1292)
The article in the July 14th issue contained an error in the last sentence of the last paragraph beginning on page 55. The instrument's reading is determined not by the degree of protrusion of the tympanic...
The article in the July 14th issue contained an error in the last sentence of the last paragraph beginning on page 55. The instrument's reading is determined not by the degree of protrusion of the tympanic membrane, but rather by its mobility.
Med Lett Drugs Ther. 2008 Aug 11;50(1292):64 | Show Full IntroductionHide Full Introduction